Medical

Avalue Technology, a global pioneer in industrial computing solutions, announces the release of its latest HID-1540, a 15.6” medical all-in-one panel PC. Powered by the 12th generation Intel Core Alder Lake-PS processor platform, the HID-1540 is designed to optimise hospital operations, supporting critical care monitoring, medical imaging, and hospital data management.

Drug discovery has long been compared to assembling a jigsaw puzzle, with new drugs needing to be precisely shaped to fit the proteins in the human body to achieve therapeutic effects. This intricate process is time-consuming and complex, but researchers at Southern Methodist University (SMU) have introduced a new tool to speed up the process: SmartCADD.

A project to improve the early detection of inflammatory arthritis using machine learning and AI has received £600,000 from UK Research and Innovation. The project will develop an AI-based system to help doctors diagnose arthritis more quickly and accurately.

The EIRE300 series from Vox Power combines compact design with exceptional reliability & efficiency, delivering 300W with a peak output of 375W within a small 4” x 2” footprint and slim 1” profile. It offers versatility with unrivalled convection-cooled ratings of 200W (115VAC), making it suitable for a wide range of applications.

Bristol-based health technology startup, Siloton, has secured £860,000 in new funding to accelerate the commercial launch of its eye imaging chip technology, aimed at tackling the UK's most common cause of sight loss.

OMNIVISION and Philips will jointly demonstrate a prototype of the world’s first in-cabin connected wellbeing monitoring solution at AutoSens Europe, taking place 8-10th October, 2024, at Palau de Congressos, Barcelona, Spain.

As wearables become more common, more patients and providers expect incremental functionality, performance and longevity improvements.

Photobleaching poses a substantial challenge in medical imaging, potentially compromising the accuracy and reliability of fluorescent-based techniques of various applications.

RECOM has launched new cost-effective DC/DCs with the highest level of medical isolation in through-hole and SMD formats.

NaNotics LLC, a biopharmaceutical firm pioneering the development of NaNots – subtractive nanoparticles designed to remove harmful molecules from the bloodstream – announced its selection for the SPACE-H Accelerator programme.